Publications by authors named "Jennifer von Luckner"
[Equine piroplasmosis: Case descriptions and overview of the epidemiological situation in Europe with focus on Germany].
Tierarztl Prax Ausg G Grosstiere Nutztiere
December 2024
Article Synopsis
- Equine piroplasmosis (EP) is caused by specific pathogens transmitted through hard ticks, primarily found in the Mediterranean region, but cases have emerged in central Europe, raising concerns.
- Horses traveling to or imported from endemic areas face infection risks, with common clinical signs including fever and anemia, while diagnostics include various testing methods.
- Treatment involves Imidocarb-dipropionate; however, some infections can lead to lifelong carrier statuses, posing economic challenges and requiring serological screening under international guidelines.
Fibroblast growth factor (FGF)-23 is a phosphaturic hormone. An association between increasing FGF-23 levels and progression of chronic kidney disease (CKD) was documented in cats, dogs, and humans. The information regarding reference intervals (RIs) of FGF-23 in cats is limited.
View Article and Find Full Text PDFIn dogs, hemophilia A is known to affect different breeds. This is a case report describing hemophilia A in a litter of Border Collies. A privately owned bitch and her puppies (n = 7) were presented to the referring veterinarian after acute hematoma formation in the male offspring (n = 3) following microchip implantation.
View Article and Find Full Text PDFFibroblast growth factor-23 (FGF-23) is a phosphaturic hormone used to monitor chronic kidney disease (CKD) in humans. The aim of this pilot study was to compare three diagnostic assays and to assess how the results correlate with parameters of renal dysfunction in cats. Four groups of 10 cats each were formed retrospectively according to creatinine, based on IRIS staging.
View Article and Find Full Text PDFBackground: Liver function tests do not always normalize despite successful attenuation of extrahepatic portosystemic shunts (EHPSS).
Objectives: Assess the lidocaine/monoethylglycylxylidide (MEGX) test to determine liver perfusion after EHPSS closure.
Animals: Twenty dogs with EHPSS.